| Literature DB >> 29866151 |
Marco Zanobini1, Claudia Loardi1, Paolo Poggio1, Gloria Tamborini1, Fabrizio Veglia1, Alessandro Di Minno1, Veronika Myasoedova1, Liborio Francesco Mammana1, Raoul Biondi1, Mauro Pepi1, Francesco Alamanni1, Matteo Saccocci2,3.
Abstract
BACKGROUND: The reduction of RV function after cardiac surgery is a well-known phenomenon. It could persist up-to one year after the operation and often leads to an incomplete recovery at follow-up echocardiographic control. The aim of the present study is to analyze the impact of different modalities of pericardial incision (lateral versus anterior) and of myocardial protection protocols (Buckberg versus Custodiol) onto postoperative RV dynamic by relating two- and three-dimensional echocardiographic parameters in patients undergoing mitral valve repair through minimally invasive or traditional surgery approach.Entities:
Keywords: Cardioplegia; Echocardiography; Minimally invasive surgery; Mitral valve; Right ventricle; Valve repair
Mesh:
Year: 2018 PMID: 29866151 PMCID: PMC5987597 DOI: 10.1186/s13019-018-0726-5
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Fig. 1Design of the study
Clinical and echocardiographic groups’ baseline characteristics
| Group 1 ( | Group 2 | Group 3 ( | ||
|---|---|---|---|---|
| Age, y | 54.8 ± 11.9 | 59.2 ± 10.2 | 50.9 ± 12.2 | 0.14 |
| Male, n (%) | 13 (76%) | 7 (70%) | 14 (82%) | 0.18 |
| BSA (m2) | 1.9 ± 0.2 | 1.8 ± 0.2 | 1.8 ± 0.1 | 0.32 |
| EuroSCORE 2* | 0.98% | 0.96% | 0.95% | 0.45 |
| LVEF | 60.4 ± 6.4 | 58.2 ± 4.1 | 64.5 ± 4.7 | 0.32 |
| TAPSE (mm) | 24.5 ± 4.8 | 27.4 ± 5.3 | 23.5 ± 4 | 0.17 |
| SPAP (mmHg) | 33.9 ± 4.8 | 32.3 ± 5.1 | 34.9 ± 2.7 | 0.83 |
| RVEF (3D) | 62.2 ± 8.9 | 60.5 ± 8.2 | 58.5 ± 6.1 | 0.56 |
| RVSV (3D) | 68.3 ± 23.9 | 54.1 ± 18.8 | 68 ± 13.1 | 0.21 |
| RVESV (3D) | 43.4 ± 22.5 | 34.7 ± 11.7 | 48.5 ± 11.6 | 0.34Ɨ |
| RVEDV (3D) | 111.7 ± 42.8 | 88.8 ± 26.1 | 116.5 ± 19.8 | 0.18φ |
| MVP Type | ||||
| Posterior leaflet prolapse | 17 | 9 | 17 | |
| Anterior leaflet prolapse | 2 | 1 | 1 | |
*EuroSCORE 2 denotes the European System for Cardiac Operative Risk Evaluation (2nd version)
Ɨp = 0.04 Group 2 versus 3
φp = 0.03 Group 2 versus 3
BSA Indicates body surface area, LVEF Left ventricular ejection fraction, TAPSE Tricuspid annular plane systolic excursion, SPAP Systolic pulmonary arterial pressure, RVEF Right ventricular ejection fraction, RVSV Right ventricular stroke volume, RVESV Right ventricular end-systolic volume, RVEDV Right ventricular end-diastolic volume, MVP Mitral valve prolapse
Composition of cardioplegic solutions used in the study
| Ingredient | Buckberg cold induction 4.1 | Buckberg cold maintenance 4.1 | Buckberg “hot shot” | Custodiol |
|---|---|---|---|---|
| Na+ | 140 | 140 | 140 | 15 |
| K+ | 20 | 10 | 8 | 9 |
| Mg++ | 13 | 9 | 6 | 4 |
| Ca++ | – | – | – | 0.015 |
| Hystidine | – | – | – | 198 |
| Tryptophan | – | – | – | 2 |
| Ketoglutarate | – | – | – | 1 |
| Mannitol | – | – | – | 30 |
| Glucose | 6 | 6 | 8 | – |
| pH | 7.2 | 7.4 | 7.5 | 7.02–7.2 |
All ingredients are expressed in mmol/L
Intraoperative groups’ characteristics
| Group 1 | Group 2 ( | Group 3 ( | ||
|---|---|---|---|---|
| CPB time (min) | 113 ± 17 | 105 ± 18 | 131 ± 23 | 0.21 |
| Cross-clamp time (min) | 95 ± 13 | 93 ± 12 | 112 ± 12 | 0.24 |
| Complete prosthetic semi-rigid ring | 3 | 2 | 2 | 0.32 |
| Incomplete band | 14 | 8 | 15 | 0.25 |
| Annular plication | 1 | 0 | 0 | 0.43 |
| Quadrangular resection | 6 | 4 | 7 | 0.44 |
| Triangular resection | 9 | 5 | 9 | 0.28 |
| Sliding-plasty | 5 | 4 | 6 | 0.12 |
| Artificial chordae positioning | 2 | 1 | 1 | 0.23 |
| Papillary muscle plication | 1 | 0 | 0 | 0.34 |
CPB Indicates cardio-pulmonary bypass
Two-dimensional and three-dimensional echocardiographic parameters measured at pre- and 6 months post-surgery
| Variable | Pre-surgery | Sixth month | P Within Group |
|---|---|---|---|
| TAPSE (mm) | |||
| Group 1 | 24.5 ± 4.8 | 14.9 ± 3 | < 0.0001 |
| Group 2 | 27.4 ± 5.3 | 19.3 ± 4.2 | 0.0003 |
| Group 3 | 23.5 ± 4 | 21.5 ± 4.1 | 0.013 |
| SPAP (mmHg) | |||
| Group 1 | 33.9 ± 4.8 | 25.7 ± 2.9 | < 0.0001 |
| Group 2 | 32.3 ± 5.1 | 28.3 ± 6.5 | 0.054 |
| Group 3 | 34.9 ± 8.1 | 25.2 ± 3.1 | 0.049 |
| RVEDV (ml) | |||
| Group 1 | 111.7 ± 42.8 | 93.1 ± 26.2 | 0.016 |
| Group 2 | 88.8 ± 26.1 | 72.2 ± 21.3 | 0.002 |
| Group 3 | 116.5 ± 19.8 | 105.2 ± 20.6 | 0.039 |
| RVESV (ml) | |||
| Group 1 | 43.4 ± 22.5 | 39.2 ± 13.6 | 0.244 |
| Group 2 | 34.7 ± 11.7 | 29.2 ± 9.2 | 0.048 |
| Group 3 | 48.5 ± 11.6 | 41 ± 9 | 0.005 |
| 3D RVEF (%) | |||
| Group 1 | 62.2 ± 8.9 | 58.2 ± 5.4 | 0.021 |
| Group 2 | 60.5 ± 8.2 | 59.5 ± 6.9 | 0.579 |
| Group 3 | 58.5 ± 6.1 | 60.7 ± 6.8 | 0.207 |
| 3D RVSV (ml) | |||
| Group 1 | 68.3 ± 23.9 | 53.9 ± 13.9 | 0.004 |
| Group 2 | 54.1 ± 18.8 | 43 ± 14.1 | 0.0039 |
| Group 3 | 68 ± 13.1 | 64.1 ± 15.9 | 0.349 |
TAPSE Indicates tricuspid annular plane systolic excursion, SPAP Systolic pulmonary arterial pressure, RVEDV Right ventricular end-diastolic volume, RVESV Right ventricular end-systolic volume, RVEF Right ventricular ejection fraction, RVSV Right ventricular stroke volume
Inter-group comparison of two-dimensional and three-dimensional echocardiographic parameters variations (6 months post-surgery versus pre-operative values)
| Delta variable | Group 1 | Group 2 | Group 3 | |||
|---|---|---|---|---|---|---|
| TAPSE(mm) | −9.5 | −8.1 | −2 | < 0.0001 | 0.12 | 0.008 |
| SPAP(mmHg) | −8.1 | −4 | −9.7 | 0.66 | 0.86 | 0.65 |
| RVEDV (ml) | −18.6 | −16.5 | −11.3 | 0.54 | 0.93 | 0.51 |
| RVESV (ml) | −4.2 | −5.5 | −7.4 | 0.49 | 0.69 | 0.91 |
| 3D RVEF (%) | −3.9 | −0.9 | 2.2 | 0.04 | 0.22 | 0.74 |
| 3D RVSV(ml) | −14.4 | −11.1 | −3.9 | 0.18 | 0.66 | 0.45 |
| 2D LVEF (%) | −7.6 | −8.1 | −3.8 | 0.08 | 0.84 | 0.19 |
TAPSE indicates tricuspid annular plane systolic excursion, SPAP systolic pulmonary arterial pressure, RVEDV right ventricular end-diastolic volume, RVESV right ventricular end-systolic volume, RVEF right ventricular ejection fraction, RVSV right ventricular stroke volume, LVEF left ventricular ejection fraction
Fig. 2PANEL a - Mean tricuspid annular plane systolic excursion (TAPSE) and 95% confidence intervals (CIs) measured preoperatively and at 6 months postoperatively. * Between-groups comparison. Ɨ p < 0.05 vs preoperative; PANEL b - Mean three-dimensional right ventricular ejection fraction (3D RVEF) and 95% confidence intervals (CIs) measured preoperatively and at 6 months postoperatively. * Between-groups comparison Ɨ p < 0.05 vs preoperative; Panel c - Mean three-dimensional right ventricular stroke volume (3D RVSV) and 95% confidence intervals (CIs) measured preoperatively and at 6 months postoperatively. Ɨ p < 0.05 vs preoperative